Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Clipson

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Molecular Diagnostics : JMD|July 14, 2015
Somatic Mutation Screening Using Archival Formalin-Fixed, Paraffin-Embedded Tissues by Fluidigm Multiplex PCR and Illumina SequencingMing Wang, Leire Escudero-Ibarz, Sarah Moody, et al.
The Journal of Pathology|July 7, 2017
Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphomaSarah Moody, Leire Escudero-Ibarz, Ming Wang, et al.
EMBO Molecular Medicine|March 6, 2026
Cell-free DNA methylome and fragmentome analysis for relapse monitoring of Ewing sarcomaSophie A Richardson, Aram Safrastyan, Mina Karimpour, et al.
Nature Communications|April 17, 2024
A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primaryAlicia-Marie Conway, Simon P Pearce, Alexandra Clipson, et al.
BMJ Open|December 26, 2024
Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) - study protocol paper for a phase III multicentre, open-label randomised controlled trialFinbar Slevin, Sophie Alexander, Sarah R Brown, et al.
Leukemia|December 18, 2019
Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hitFrancesco Cucco, Sharon Barrans, Chulin Sha, et al.
The Lancet. Oncology|April 6, 2019
Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trialAndrew Davies, Thomas E Cummin, Sharon Barrans, et al.
Nature Cancer|August 8, 2022
cfDNA methylome profiling for detection and subtyping of small cell lung cancersFrancesca Chemi, Simon P Pearce, Alexandra Clipson, et al.
The Journal of Pathology. Clinical Research|June 28, 2016
The prognosis of <i>MYC</i> translocation positive diffuse large B-cell lymphoma depends on the second hitAlexandra Clipson, Sharon Barrans, Naiyan Zeng, et al.
The Journal of Pathology|December 21, 2019
Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cellWen-Qing Yao, Fangtian Wu, Wenyan Zhang, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Molecular Diagnostics : JMD|July 14, 2015
Somatic Mutation Screening Using Archival Formalin-Fixed, Paraffin-Embedded Tissues by Fluidigm Multiplex PCR and Illumina SequencingMing Wang, Leire Escudero-Ibarz, Sarah Moody, et al.
The Journal of Pathology|July 7, 2017
Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphomaSarah Moody, Leire Escudero-Ibarz, Ming Wang, et al.
EMBO Molecular Medicine|March 6, 2026
Cell-free DNA methylome and fragmentome analysis for relapse monitoring of Ewing sarcomaSophie A Richardson, Aram Safrastyan, Mina Karimpour, et al.
Nature Communications|April 17, 2024
A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primaryAlicia-Marie Conway, Simon P Pearce, Alexandra Clipson, et al.
BMJ Open|December 26, 2024
Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) - study protocol paper for a phase III multicentre, open-label randomised controlled trialFinbar Slevin, Sophie Alexander, Sarah R Brown, et al.
Leukemia|December 18, 2019
Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hitFrancesco Cucco, Sharon Barrans, Chulin Sha, et al.
The Lancet. Oncology|April 6, 2019
Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trialAndrew Davies, Thomas E Cummin, Sharon Barrans, et al.
Nature Cancer|August 8, 2022
cfDNA methylome profiling for detection and subtyping of small cell lung cancersFrancesca Chemi, Simon P Pearce, Alexandra Clipson, et al.
The Journal of Pathology. Clinical Research|June 28, 2016
The prognosis of <i>MYC</i> translocation positive diffuse large B-cell lymphoma depends on the second hitAlexandra Clipson, Sharon Barrans, Naiyan Zeng, et al.
The Journal of Pathology|December 21, 2019
Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cellWen-Qing Yao, Fangtian Wu, Wenyan Zhang, et al.
Pageof 3